We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

86 hedge funds and large institutions have $1.12B invested in Loxo Oncology, Inc in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 17

66% more capital invested

Capital invested by funds: $677M → $1.12B (+$447M)

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

0% more funds holding

Funds holding: 86 → 86 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
43
Reduced
17
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$54.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$25.3M
5
DM
Deerfield Management
New York
+$20.7M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$6.63M
2
Victory Capital Management
Victory Capital Management
Texas
-$6.14M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.8M
4
Teacher Retirement System of Texas
Teacher Retirement System of Texas
Texas
-$1.74M
5
CLCM
Crawford Lake Capital Management
New Jersey
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
26
Axa
France
$7.13M -$1.39M -33,706 -17%
Lord, Abbett & Co
27
Lord, Abbett & Co
New Jersey
$6.59M +$6.45M +156,678 New
BBA
28
Baker Bros. Advisors
New York
$5.8M – – –
Geode Capital Management
29
Geode Capital Management
Massachusetts
$5.73M +$1.82M +44,193 +48%
OM
30
Opaleye Management
Massachusetts
$5.47M +$206K +5,000 +4%
EI
31
EAM Investors
California
$4.34M -$334K -8,119 -7%
CS
32
Candriam SCA
Luxembourg
$4.33M +$947K +23,000 +29%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$4.31M +$1.24M +30,210 +42%
SSA
34
Schonfeld Strategic Advisors
New York
$4.21M +$2.19M +53,147 +113%
FCMI
35
Foresite Capital Management III
California
$4.21M +$4.12M +100,000 New
PC
36
PointState Capital
New York
$3.85M +$3.77M +91,600 New
SAM
37
Sectoral Asset Management
Quebec, Canada
$3.8M +$3.72M +90,390 New
CS
38
Credit Suisse
Switzerland
$3.27M +$1.46M +35,506 +84%
Charles Schwab
39
Charles Schwab
California
$3.11M +$1.26M +30,533 +70%
USAA
40
United Services Automobile Association
Texas
$2.97M – – –
AG
41
Artal Group
Luxembourg
$2.73M -$1.44M -35,000 -35%
JP Morgan Chase
42
JP Morgan Chase
New York
$2.21M -$1.8M -43,604 -45%
Fidelity International
43
Fidelity International
Bermuda
$1.94M +$1.9M +46,114 New
Goldman Sachs
44
Goldman Sachs
New York
$1.86M +$84.2K +2,045 +5%
TCIM
45
TIAA CREF Investment Management
New York
$1.72M +$149K +3,614 +10%
PPA
46
Parametric Portfolio Associates
Washington
$1.59M +$1.55M +37,679 New
Deutsche Bank
47
Deutsche Bank
Germany
$1.51M +$658K +15,982 +80%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$1.49M -$785K -19,061 -35%
Ameriprise
49
Ameriprise
Minnesota
$1.37M -$95K -2,306 -7%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.34M +$177K +4,300 +16%
1
2
3 4

LOXO Hedge Fund Activity: Q1 2017 in Review

86 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2017, worth a combined $1.12B — up 66% from $677M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new LOXO positions and 13 closed out — a net gain of 5 holders — while 43 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock, adding an estimated $54.7M. The largest seller was Eventide Asset Management, cutting an estimated $6.63M.

  • 86 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $1.12B of Loxo Oncology, Inc stock for Q1 2017, up 66% quarter-over-quarter.
  • 18 funds opened new Loxo Oncology, Inc positions in Q1 2017 and 13 closed out, a net change of +5 holders.
  • The largest Loxo Oncology, Inc buyer in Q1 2017 was BlackRock, an estimated $54.7M added.
  • The largest Loxo Oncology, Inc seller in Q1 2017 was Eventide Asset Management, an estimated $6.63M sold.

Based on aggregated 13F filings for Q1 2017.